---
schema_version: "secwatch.filing_event.v1"
accession: "0001818331-26-000039"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-15T00:00:09.245504+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# GeneDx Q1 revenue $102.3M (+17% YoY); exome/genome volume +34%; FY guidance $475-490M

## Summary
- Q1 revenue $102.3M (+17% YoY); exome/genome revenue $90.6M (+27% YoY).
- Exome/genome volume 27,488 (+34% YoY); adjusted gross margin 69% flat YoY.
- GAAP net loss $63.3M; adjusted net loss $8.2M vs adjusted net income $9.2M in Q1 2025.
- Full-year 2026 revenue guidance $475-$490M with at least 30% exome/genome volume growth; cash $171.7M.

## SEC filing metadata
- accession: 0001818331-26-000039
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000181833126000039/0001818331-26-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000181833126000039/wgs-20260504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818331-26-000039
- JSON: https://secwatch.observer/filing/0001818331-26-000039.json
- Plain text: https://secwatch.observer/filing/0001818331-26-000039.txt

## Key facts
- Earnings Releases
  GeneDx Holdings Corp. reported first quarter of 2026 results: revenue $102.3 million, net income $63.3 million.
  - Period: first quarter of 2026
  - Revenue: $102.3 million
  - Net income: $63.3 million
  - Result: reported results
  source text: reported first quarter 2026 revenue of $102.3 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833126000039/0001818331-26-000039-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.